Form 4 for CRM Salesforce
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001127602-21-031883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-23 | 2021-12-22 | CRM | Taylor Bret Steven | Vice COB of the Board, CoCEO, Dir | M - OptEx | $0.00 | +2,291 | 925.7K | +0.2% | $0 |
| D | 2021-12-23 | 2021-12-23 | CRM | Taylor Bret Steven | Vice COB of the Board, CoCEO, Dir | S - Sale+OE | $251.47 | -1,151 | 924.5K | -0.1% | -$289.4K |
| DM | 2021-12-23 | 2021-12-22 | CRM | Taylor Bret Steven | Vice COB of the Board, CoCEO, Dir | M - OptEx | $0.00 | -2,291 | 1,324 | -63% | $0 |
| DM | 2021-12-23 | 2021-12-22 | CRM | Taylor Bret Steven | Vice COB of the Board, CoCEO, Dir | A - Grant | $172.44 | +44.3K | 14.1K | New | +$7.64M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | M | A | 1,324 | $0.00 | 924,706 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-22 | M | A | 967 | $0.00 | 925,673 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-23 | S | D | 1,151 | $251.47 | 924,522 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2021-12-22 | M | D | 967 | $0.00 | 4,838 | D | $0.00 · 2020-03-22 to 2023-03-22 | 967 Common Stock | (F5) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F7) These restricted stock units vested as to 25% of the original grant on March 22, 2020 and vest as to 1/16 of the original grant quarterly thereafter. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-12-22 | A | A | 30,226 | $252.80 | 30,226 | D | $252.80 · 2022-12-22 to 2028-12-22 | 30,226 Common Stock | (F4) Option vests over four years at the rate of 25% on December 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 6 | Derivative | Performance-Based Restricted Stock Units | 2021-12-22 | A | A | 14,087 | $0.00 | 14,087 | D | $0.00 · 2025-01-15 to 2025-01-15 | 14,087 Common Stock | (F2) Each performance-based restricted stock unit, or PRSU, represents a contingent right to receive one share of Issuer common stock. (F3) The PRSUs will vest depending on Issuer's total shareholder return ("TSR") over the three-year period from the grant date (the "Performance Period"), relative to companies in the NASDAQ-100 Index as of the grant date (the "Index Group"). If Issuer's TSR over the Performance Period is at the 60th percentile when ranked against the Index Group TSRs, 100% of the target number of shares will vest. For every percentile by which Issuer's TSR ranking within the Index Group exceeds the 60th percentile, shares vesting will increase by 3 and 1/3%, up to a maximum payout of 200% of target if Issuer's TSR ranking is at the 99th percentile. For every percentile by which Issuer's TSR ranking within the Index Group is below the 60th percentile, shares vesting will decrease by 2 and 22/39%, with no payout if Issuer's TSR ranking is below the 30th percentile. If Issuer's absolute TSR over the Performance Period is negative, the number of shares vesting will not exceed 100% of target. |
| 7 | Derivative | Restricted Stock Units | 2021-12-22 | M | D | 1,324 | $0.00 | 1,324 | D | $0.00 · 2019-03-22 to 2022-03-22 | 1,324 Common Stock | (F5) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F6) These restricted stock units vested as to 25% of the original grant on March 22, 2019 and vest as to 1/16 of the original grant quarterly thereafter. |